These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 834143)

  • 1. Influence of physiologic hyperglucagonemia on urinary glucose, nitrogen, and electrolyte excretion in diabetes.
    Sherwin RS; Hendler R; Felig P
    Metabolism; 1977 Jan; 26(1):53-8. PubMed ID: 834143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperglucagonemia and its suppression. Importance in the metabolic control of diabetes.
    Raskin P; Unger RH
    N Engl J Med; 1978 Aug; 299(9):433-6. PubMed ID: 683275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of exogenous hyperglucagonemia in insulin-treated diabetics.
    Raskin P; Unger RH
    Diabetes; 1977 Nov; 26(11):1034-9. PubMed ID: 410690
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of intermittent endogenous hyperglucagonemia on glucose homeostasis in normal and diabetic man.
    Rizza R; Verdonk C; Miles J; Service FJ; Gerich J
    J Clin Invest; 1979 Jun; 63(6):1119-23. PubMed ID: 447838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of basal insulin and glucagon secretion on potassium and sodium metabolism. Studies with somatostatin in normal dogs and in normal and diabetic human beings.
    DeFronzo RA; Sherwin RS; Dillingham M; Hendler R; Tamborlane WV; Felig P
    J Clin Invest; 1978 Feb; 61(2):472-9. PubMed ID: 621284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of chronic insulin therapy on phosphate metabolism in diabetes mellitus.
    Raskin P; Pak CY
    Diabetologia; 1981 Jul; 21(1):50-3. PubMed ID: 7024029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of counterregulatory hormones in the catabolic response to stress.
    Gelfand RA; Matthews DE; Bier DM; Sherwin RS
    J Clin Invest; 1984 Dec; 74(6):2238-48. PubMed ID: 6511925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of glucagon on protein metabolism in normal man.
    Wolfe BM; Culebras JM; Aoki TT; O'Connor NE; Finley RJ; Kaczowka A; Moore FD
    Surgery; 1979 Aug; 86(2):248-57. PubMed ID: 380036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of nitrogen from organs in rats induced by exogenous glucagon.
    Almdal TP; Vilstrup H
    Endocrinology; 1988 Nov; 123(5):2182-6. PubMed ID: 3049048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperglucagonemia and blood glucose regulation in normal, obese and diabetic subjects.
    Sherwin RS; Fisher M; Hendler R; Felig P
    N Engl J Med; 1976 Feb; 294(9):455-61. PubMed ID: 1246330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans.
    Saccà L; Sherwin R; Hendler R; Felig P
    J Clin Invest; 1979 May; 63(5):849-57. PubMed ID: 447832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of uremia and hemodialysis on the turnover and metabolic effects of glucagon.
    Sherwin RS; Bastl C; Finkelstein FO; Fisher M; Black H; Hendler R; Felig P
    J Clin Invest; 1976 Mar; 57(3):722-31. PubMed ID: 1249205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the sodium-glucose cotransporter 2 (SGLT2) inhibitor velagliflozin, a new drug with therapeutic potential to treat diabetes in cats.
    Hoenig M; Clark M; Schaeffer DJ; Reiche D
    J Vet Pharmacol Ther; 2018 Apr; 41(2):266-273. PubMed ID: 29139146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of hyperglucagonemia on blood glucose concentrations and on insulin requirements in insulin-requiring diabetes mellitus.
    Clarke WL; Santiago JV; Kipnis DM
    Diabetes; 1978 Jun; 27(6):649-52. PubMed ID: 658610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of intermittent physiologic hyperglucagonemia on postprandial plasma glucose levels in normal man.
    Mackes K; Rizza R; Gerich J
    Metabolism; 1981 Nov; 30(11):1041-4. PubMed ID: 7026969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of surgical trauma and insulin on whole-body protein turnover in parenterally-fed undernourished patients.
    Powell-Tuck J; Fern EB; Garlick PJ; Waterlow JC
    Hum Nutr Clin Nutr; 1984 Jan; 38(1):11-22. PubMed ID: 6420374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of xylitol on urea synthesis in normal humans: relation to glucagon.
    Hamberg O; Almdal TP
    JPEN J Parenter Enteral Nutr; 1996; 20(2):139-44. PubMed ID: 8676533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperglucagonemia during insulin deficiency accelerates protein catabolism.
    Nair KS; Halliday D; Matthews DE; Welle SL
    Am J Physiol; 1987 Aug; 253(2 Pt 1):E208-13. PubMed ID: 3303968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal sodium conservation during starvation in the rat.
    Van Liew JB; Eisenbach GM; Dlouha H; Boylan JW
    J Lab Clin Med; 1978 Apr; 91(4):650-9. PubMed ID: 641388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reference limits for urinary fractional excretion of electrolytes in adult non-racing Greyhound dogs.
    Bennett SL; Abraham LA; Anderson GA; Holloway SA; Parry BW
    Aust Vet J; 2006 Nov; 84(11):393-7. PubMed ID: 17092324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.